期刊文献+

经颅超声在早期帕金森病鉴别诊断中的应用进展 被引量:4

Application of transcranial sonography in the differential diagnosis of early Parkinson disease
原文传递
导出
摘要 黑质经颅超声(TCS)检查对帕金森病(PD)的诊断具有重要价值。TCS已被推荐用于测定第三脑室宽度、PD的早期诊断与鉴别诊断、深部脑刺激(DBS)术后电极位置管理等,随着研究的不断深入及操作流程的日益规范,TCS较高的阳性预测值及其廉价、便利、无创等特点,使有望常规应用于PD的早期诊断与鉴别诊断。 Transcranial sonography (TCS) of the substantia nigra (SN) is a new and promising method to diagnose Parkinson's disease (PD). TCS is currently recommended in clinical practice for the assessment of the 3rd ventricle widths, the early and differential diagnosis of PD, and the post-operative position control of DBS electrodes. The high positive predictive value of TCS highlights its possible utility as a routine diagnostic test for early and differential diagnosis of PD.
出处 《中华临床医师杂志(电子版)》 CAS 2016年第6期873-876,共4页 Chinese Journal of Clinicians(Electronic Edition)
关键词 帕金森病 经颅超声 鉴别诊断 Parkinson disease Transcranial sonography Differential diagnosis
  • 相关文献

参考文献31

  • 1Kones R. Mitochondrial therapy for Parkinson's disease:neuroprotective pharmaconutrition may be disease-modifying[J].Clin Pharmacol, 2010, 2: 185-198.
  • 2Chinta SJ, Andersen JK. Dopaminergic neurons[J]. Int J BiochemCell Biol, 2005, 37(5): 942-946.
  • 3Felicio AC, Shih MC, Godeiro-Junior C, et al. Molecular imagingstudies in Parkinson disease: reducing diagnostic uncertainty[J].Neurologist, 2009, 15(1): 6-16.
  • 4Kurata T, Kametaka S, Ohta Y, et al. PSP as distinguished fromCBD, MSA-P and PD by clinical and imaging differences at an earlystage[J]. Intern Med, 2011, 50(22): 2775-2781.
  • 5Becker G, Seufert J, Bogdahn U, et al. Degeneration of substantianigra in chronic Parkinson's disease visualized by transcranialcolor-coded real-time sonography[J]. Neurology, 1995, 45(1):182-184.
  • 6Sadowski K, Serafin-Król M, Szlachta K, et al. Basal ganglia echogenicity in tauopathies[J]. J Neural Transm, 2015, 122(6):863-865.
  • 7Berg D, Roggendorf W, Schr-der U, et al. Echogenicity of thesubstantia nigra: association with increased iron content and markerfor susceptibility to nigrostriatal injury[J]. Arch Neurol, 2002, 59(6):999-1005.
  • 8Schweitzer KJ, Hilker R, Walter U, et al. Substantia nigrahyperechogenicity as a marker of predisposition and slowerprogression in Parkinson-s disease[J]. Mov Disord, 2006, 21(1):94-98.
  • 9Berg D. Transcranial ultrasound as a risk marker for Parkinson-sdisease[J]. Mov Disord, 2009, 24 Suppl 2: S677-683.
  • 10Doepp F, Plotkin M, Siegel L, et al. Brain parenchyma sonographyand 1231-FP-CIT SPECT in Parkinson-s disease and essential tremor[J]. Mov Disord, 2008, 23(3): 405-410.

同被引文献18

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部